Aurora Spine Corporation
ASAPF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $4 | $4 | $4 | $5 |
| % Growth | -2.6% | 1.8% | -3.3% | – |
| Cost of Goods Sold | $3 | $2 | $2 | $2 |
| Gross Profit | $1 | $3 | $3 | $1 |
| % Margin | 25.5% | 62.2% | 58% | 23.2% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $2 | $2 | $2 | $2 |
| SG&A Expenses | $2 | $2 | $2 | $3 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$1 | $0 | $0 | $0 |
| Operating Expenses | $1 | $3 | $3 | $3 |
| Operating Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -1.7% | -2.9% | -6.2% | -9.7% |
| Other Income/Exp. Net | -$0 | -$0 | -$0 | -$0 |
| Pre-Tax Income | -$0 | -$0 | -$0 | -$1 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$0 | -$0 | -$0 | -$1 |
| % Margin | -3.2% | -4.4% | -7.9% | -13.9% |
| EPS | -0.002 | -0.003 | -0.005 | -0.008 |
| % Growth | 30.8% | 42.2% | 45.1% | – |
| EPS Diluted | -0.002 | -0.003 | -0.005 | -0.008 |
| Weighted Avg Shares Out | 78 | 77 | 78 | 78 |
| Weighted Avg Shares Out Dil | 78 | 77 | 78 | 78 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $0 | $0 | -$0 | -$0 |
| % Margin | 3.2% | 2.7% | -0.9% | -7.4% |